Back to Search
BRITTANY VAN NESS, MD
MD
Psychiatry Physician
NPI: 1902433170IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
M-17787(ID)
CMS Specialties
PrimaryPSYCHIATRY
Education
OTHER
Class of 2020
Research & Publications (20)
Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.
PMID 19657367·Leukemia·2009
8-other
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping.
PMID 18805967·Blood·2008
8-other
Deregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitors.
PMID 19017943·J Immunol·2008
7-preclinical
Managing incidental findings in human subjects research: analysis and recommendations.
PMID 18547191·J Law Med Ethics·2008
6-review
Clinical and biological significance of RAS mutations in multiple myeloma.
PMID 18528420·Leukemia·2008
8-other
Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.
PMID 18778477·BMC Med·2008
8-other
A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma.
PMID 17483317·Cancer Res·2007
7-preclinical
The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells.
PMID 17222906·Leuk Res·2007
7-preclinical
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications.
PMID 16840723·Blood·2007
8-other
Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantation.
PMID 16565956·Cancer·2006
2-rct
The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype.
PMID 16007202·Oncogene·2005
7-preclinical
ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
PMID 15725478·Leuk Res·2005
7-preclinical
Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies.
PMID 14656874·Blood·2004
7-preclinical
Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.
PMID 15199411·J Clin Invest·2004
7-preclinical
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.
PMID 14671610·Hematol J·2003
6-review
Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cells.
PMID 12813136·Mol Cancer Ther·2003
8-other
Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells.
PMID 12791645·Blood·2003
4-observational
Clinical and biologic implications of recurrent genomic aberrations in myeloma.
PMID 12576322·Blood·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 9850 W ST LUKES DR STE 320
NAMPA, ID 83687 - Phone
- (208) 505-2222
Quick Facts
- NPI
- 1902433170
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile